nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Megacolon toxic—Methotrexate—esophageal cancer	0.127	0.127	CcSEcCtD
Lincomycin—Abdominal distress—Methotrexate—esophageal cancer	0.078	0.078	CcSEcCtD
Lincomycin—Megacolon—Methotrexate—esophageal cancer	0.0643	0.0643	CcSEcCtD
Lincomycin—Phlebitis—Carboplatin—esophageal cancer	0.0552	0.0552	CcSEcCtD
Lincomycin—Pruritus genital—Capecitabine—esophageal cancer	0.0339	0.0339	CcSEcCtD
Lincomycin—Abscess—Cisplatin—esophageal cancer	0.0243	0.0243	CcSEcCtD
Lincomycin—Pain—Carboplatin—esophageal cancer	0.02	0.02	CcSEcCtD
Lincomycin—Azotaemia—Methotrexate—esophageal cancer	0.0198	0.0198	CcSEcCtD
Lincomycin—Body temperature increased—Carboplatin—esophageal cancer	0.0185	0.0185	CcSEcCtD
Lincomycin—Phlebitis—Cisplatin—esophageal cancer	0.0162	0.0162	CcSEcCtD
Lincomycin—Proteinuria—Capecitabine—esophageal cancer	0.0161	0.0161	CcSEcCtD
Lincomycin—Protein urine present—Capecitabine—esophageal cancer	0.0159	0.0159	CcSEcCtD
Lincomycin—Colitis—Capecitabine—esophageal cancer	0.0136	0.0136	CcSEcCtD
Lincomycin—Abscess—Methotrexate—esophageal cancer	0.0133	0.0133	CcSEcCtD
Lincomycin—Oesophagitis—Capecitabine—esophageal cancer	0.013	0.013	CcSEcCtD
Lincomycin—Proteinuria—Methotrexate—esophageal cancer	0.012	0.012	CcSEcCtD
Lincomycin—Phlebitis—Capecitabine—esophageal cancer	0.0119	0.0119	CcSEcCtD
Lincomycin—Thrombophlebitis—Capecitabine—esophageal cancer	0.0119	0.0119	CcSEcCtD
Lincomycin—Protein urine present—Methotrexate—esophageal cancer	0.0118	0.0118	CcSEcCtD
Lincomycin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.0118	0.0118	CcSEcCtD
Lincomycin—Abdominal discomfort—Cisplatin—esophageal cancer	0.0116	0.0116	CcSEcCtD
Lincomycin—Pancytopenia—Cisplatin—esophageal cancer	0.0115	0.0115	CcSEcCtD
Lincomycin—Oliguria—Methotrexate—esophageal cancer	0.0114	0.0114	CcSEcCtD
Lincomycin—Glossitis—Methotrexate—esophageal cancer	0.0114	0.0114	CcSEcCtD
Lincomycin—Dermatitis bullous—Capecitabine—esophageal cancer	0.0108	0.0108	CcSEcCtD
Lincomycin—Vaginal inflammation—Methotrexate—esophageal cancer	0.0106	0.0106	CcSEcCtD
Lincomycin—Stomatitis—Cisplatin—esophageal cancer	0.0105	0.0105	CcSEcCtD
Lincomycin—Vaginal infection—Methotrexate—esophageal cancer	0.00996	0.00996	CcSEcCtD
Lincomycin—Aplastic anaemia—Methotrexate—esophageal cancer	0.00991	0.00991	CcSEcCtD
Lincomycin—Liver function test abnormal—Capecitabine—esophageal cancer	0.0095	0.0095	CcSEcCtD
Lincomycin—Tinnitus—Cisplatin—esophageal cancer	0.009	0.009	CcSEcCtD
Lincomycin—Thrombophlebitis—Methotrexate—esophageal cancer	0.00885	0.00885	CcSEcCtD
Lincomycin—Abdominal discomfort—Capecitabine—esophageal cancer	0.00853	0.00853	CcSEcCtD
Lincomycin—Pancytopenia—Capecitabine—esophageal cancer	0.00845	0.00845	CcSEcCtD
Lincomycin—Neutropenia—Capecitabine—esophageal cancer	0.00832	0.00832	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00786	0.00786	CcSEcCtD
Lincomycin—Stomatitis—Capecitabine—esophageal cancer	0.00773	0.00773	CcSEcCtD
Lincomycin—Jaundice—Capecitabine—esophageal cancer	0.00773	0.00773	CcSEcCtD
Lincomycin—Leukopenia—Cisplatin—esophageal cancer	0.00752	0.00752	CcSEcCtD
Lincomycin—Agranulocytosis—Capecitabine—esophageal cancer	0.0074	0.0074	CcSEcCtD
Lincomycin—Liver function test abnormal—Methotrexate—esophageal cancer	0.00707	0.00707	CcSEcCtD
Lincomycin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00686	0.00686	CcSEcCtD
Lincomycin—Erythema multiforme—Capecitabine—esophageal cancer	0.00673	0.00673	CcSEcCtD
Lincomycin—Tinnitus—Capecitabine—esophageal cancer	0.00664	0.00664	CcSEcCtD
Lincomycin—Hypotension—Cisplatin—esophageal cancer	0.00641	0.00641	CcSEcCtD
Lincomycin—Abdominal discomfort—Methotrexate—esophageal cancer	0.00635	0.00635	CcSEcCtD
Lincomycin—Pancytopenia—Methotrexate—esophageal cancer	0.00629	0.00629	CcSEcCtD
Lincomycin—Neutropenia—Methotrexate—esophageal cancer	0.00619	0.00619	CcSEcCtD
Lincomycin—Pain—Cisplatin—esophageal cancer	0.00587	0.00587	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00585	0.00585	CcSEcCtD
Lincomycin—Stomatitis—Methotrexate—esophageal cancer	0.00575	0.00575	CcSEcCtD
Lincomycin—Vertigo—Capecitabine—esophageal cancer	0.00557	0.00557	CcSEcCtD
Lincomycin—Leukopenia—Capecitabine—esophageal cancer	0.00555	0.00555	CcSEcCtD
Lincomycin—Agranulocytosis—Methotrexate—esophageal cancer	0.00551	0.00551	CcSEcCtD
Lincomycin—Body temperature increased—Cisplatin—esophageal cancer	0.00542	0.00542	CcSEcCtD
Lincomycin—Hypersensitivity—Cisplatin—esophageal cancer	0.00505	0.00505	CcSEcCtD
Lincomycin—Erythema multiforme—Methotrexate—esophageal cancer	0.00501	0.00501	CcSEcCtD
Lincomycin—Shock—Capecitabine—esophageal cancer	0.00498	0.00498	CcSEcCtD
Lincomycin—Tinnitus—Methotrexate—esophageal cancer	0.00494	0.00494	CcSEcCtD
Lincomycin—Hypotension—Capecitabine—esophageal cancer	0.00473	0.00473	CcSEcCtD
Lincomycin—Diarrhoea—Cisplatin—esophageal cancer	0.00469	0.00469	CcSEcCtD
Lincomycin—Vomiting—Cisplatin—esophageal cancer	0.00436	0.00436	CcSEcCtD
Lincomycin—Rash—Cisplatin—esophageal cancer	0.00433	0.00433	CcSEcCtD
Lincomycin—Pain—Capecitabine—esophageal cancer	0.00432	0.00432	CcSEcCtD
Lincomycin—Dermatitis—Cisplatin—esophageal cancer	0.00432	0.00432	CcSEcCtD
Lincomycin—Vertigo—Methotrexate—esophageal cancer	0.00414	0.00414	CcSEcCtD
Lincomycin—Leukopenia—Methotrexate—esophageal cancer	0.00413	0.00413	CcSEcCtD
Lincomycin—Nausea—Cisplatin—esophageal cancer	0.00407	0.00407	CcSEcCtD
Lincomycin—Urticaria—Capecitabine—esophageal cancer	0.00402	0.00402	CcSEcCtD
Lincomycin—Abdominal pain—Capecitabine—esophageal cancer	0.004	0.004	CcSEcCtD
Lincomycin—Body temperature increased—Capecitabine—esophageal cancer	0.004	0.004	CcSEcCtD
Lincomycin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00376	0.00376	CcSEcCtD
Lincomycin—Hypersensitivity—Capecitabine—esophageal cancer	0.00373	0.00373	CcSEcCtD
Lincomycin—Pruritus—Capecitabine—esophageal cancer	0.00358	0.00358	CcSEcCtD
Lincomycin—Hypotension—Methotrexate—esophageal cancer	0.00352	0.00352	CcSEcCtD
Lincomycin—Diarrhoea—Capecitabine—esophageal cancer	0.00346	0.00346	CcSEcCtD
Lincomycin—Pain—Methotrexate—esophageal cancer	0.00322	0.00322	CcSEcCtD
Lincomycin—Vomiting—Capecitabine—esophageal cancer	0.00322	0.00322	CcSEcCtD
Lincomycin—Rash—Capecitabine—esophageal cancer	0.00319	0.00319	CcSEcCtD
Lincomycin—Dermatitis—Capecitabine—esophageal cancer	0.00319	0.00319	CcSEcCtD
Lincomycin—Nausea—Capecitabine—esophageal cancer	0.003	0.003	CcSEcCtD
Lincomycin—Urticaria—Methotrexate—esophageal cancer	0.00299	0.00299	CcSEcCtD
Lincomycin—Abdominal pain—Methotrexate—esophageal cancer	0.00298	0.00298	CcSEcCtD
Lincomycin—Body temperature increased—Methotrexate—esophageal cancer	0.00298	0.00298	CcSEcCtD
Lincomycin—Hypersensitivity—Methotrexate—esophageal cancer	0.00277	0.00277	CcSEcCtD
Lincomycin—Pruritus—Methotrexate—esophageal cancer	0.00266	0.00266	CcSEcCtD
Lincomycin—Diarrhoea—Methotrexate—esophageal cancer	0.00258	0.00258	CcSEcCtD
Lincomycin—Vomiting—Methotrexate—esophageal cancer	0.00239	0.00239	CcSEcCtD
Lincomycin—Rash—Methotrexate—esophageal cancer	0.00237	0.00237	CcSEcCtD
Lincomycin—Dermatitis—Methotrexate—esophageal cancer	0.00237	0.00237	CcSEcCtD
Lincomycin—Nausea—Methotrexate—esophageal cancer	0.00224	0.00224	CcSEcCtD
